APIs
Novo Nordisk invests DKK 15.9bn to expand API production in Denmark
June 13, 2023Manufacturing and Production APIs, Chronic Diseases, Novo Nordisk, chronic diseases
Danish healthcare company Novo Nordisk has announced that it will invest another DKK 15.9bn into expanding an existing Active Pharmaceutical …
Trump signs deal with generics company Phlow Corp to help shift drug manufacturing to the US
May 19, 2020Manufacturing and Production APIs, COVID-19, Drugs manufacturing, coronavirus, generics
The Trump administration will sign a $354 million deal with the generics company Phlow Corp to help produce medicines and …
India reducing API exports due to coronavirus threatening global supply chain
March 4, 2020Research and Development APIs, Active Pharmaceuticals Ingredients, Big Pharma, Chinese Coronavirus, Wuhan Coronavirus, coronavirus
India is set to reduce exports of active pharmaceutical ingredients (APIs) until further notice, due to fears of internal drug …
World’s second largest API company to be created by Sanofi
February 25, 2020Manufacturing and Production API, APIs, China API, Coronavirus API, India API, Sanofi
Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …
Otsuka to take over Astellas’ Cefixime business
June 7, 2019Medical Communications APIs, Antibiotics, Astellas, Otsuka, antimicrobial, pharma
Japanese firm Otsuka Chemical has bought Astellas Pharma’s antibiotic Cefixime. The agreement gives Otsuka the right to sell Cefixime and …
US to lead global contract manufacturing market by 2020
August 11, 2015Manufacturing and Production APIs, United States, manufacturing, production
The global pharmaceutical contract manufacturing market was worth $58 billion in 2014 and is projected to reach $84 billion in 2020, according to a …
US regulator to launch ‘openFDA’
March 6, 2014Manufacturing and Production, Medical Communications APIs, FDA, data, manufacturing, open fda
The FDA is planning to introduce a new digital resource in order to open up its data to the public …
Dr Reddy’s API plant in Mexico under FDA scrutiny
June 21, 2011Manufacturing and Production APIs, Dr Reddy's, FDA, GMP violations, pharma manufacturing news
Indian drugmaker Dr Reddy’s Laboratories has been sent a warning letter by the US FDA after a manufacturing facility in …
European falsified meds directive: implications for manufacturers
June 7, 2011Manufacturing and Production APIs, GDP, GMP, excipients, pharma manufacturing
The Council of the European Union gave its backing to the new Directive on Falsified Medicines on May 27, setting …
Pfizer will invest $21m in US injectables upgrade
May 25, 2011Manufacturing and Production APIs, Pfizer, pharma manufacturing
Pfizer has announced another upgrade of its sterile injectables plant in Portage, Michigan, earmarking around $21 million for new air …
Lonza invests again in Visp high-potency capacity
May 17, 2011Manufacturing and Production APIs, HPAPIs, Lonza, manufacturing and production
Lonza has pushed further into the high-potency active pharmaceutical ingredient (HPAPI) sector with another round of investment at its manufacturing …
Helsinn expands high-potency plant with cytotoxics suite
March 8, 2011Manufacturing and Production APIs, CMOs, GMP, Helsinn, Helsinn Advanced Synthesis, Swiss pharma contract manufacturing, contract manufacturing, high-potency APIs
Helsinn is on track to complete construction of a new manufacturing plant for cytotoxic active pharmaceutical ingredients in Biasca, Switzerland, …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
